Marie Kersten

20002020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

Filter
Article
2020

Moderators of Exercise Effects on Cancer-related Fatigue: A Meta-analysis of Individual Patient Data

Van Vulpen, J. K., Sweegers, M. G., Peeters, P. H. M., Courneya, K. S., Newton, R. U., Aaronson, N. K., Jacobsen, P. B., Galvaõ, D. A., Chinapaw, M. J., Steindorf, K., Irwin, M. L., Stuiver, M. M., Hayes, S., Griffith, K. A., Mesters, I., Knoop, H., Goedendorp, M. M., Mutrie, N., Daley, A. J., McConnachie, A. & 25 others, Bohus, M., Thorsen, L., Schulz, K. H., Short, C. E., James, E. L., Plotnikoff, R. C., Schmidt, M. E., Ulrich, C. M., Van Beurden, M., Oldenburg, H. S., Sonke, G. S., Van Harten, W. H., Schmitz, K. H., Winters-Stone, K. M., Velthuis, M. J., Taaffe, D. R., Van Mechelen, W., Kersten, M. J., Nollet, F., Wenzel, J., Wiskemann, J., Verdonck-De Leeuw, I. M., Brug, J., May, A. M. & Buffart, L. M., 1 Feb 2020, In : Medicine and Science in Sports and Exercise. 52, 2, p. 303-314 12 p.

Research output: Contribution to journalArticleAcademicpeer-review

Provider caring and structuring treatment information to improve cancer patients’ recall: Does it help?

Lehmann, V., Labrie, N. H. M., van Weert, J. C. M., van Dulmen, S., de Haes, H. J. C. J. M., Kersten, M. J., Pieterse, A. H. & Smets, E. M. A., 1 Jan 2020, In : Patient Education and Counseling. 103, 1, 8 p.

Research output: Contribution to journalArticleAcademicpeer-review

2019

Effective information provision about the side effects of treatment for malignant lymphoma: Protocol of a randomized controlled trial using video vignettes

Labrie, N., van Dulmen, S., Kersten, M. J., de Haes, H. J. C. M., Pieterse, A. H., van Weert, J. C. M., van Spronsen, D. J. & Smets, E. M. A., 1 Jan 2019, In : Journal of Medical Internet Research. 21, 5, e12453.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

Fatigue, anxiety, depression and quality of life in kidney transplant recipients, haemodialysis patients, patients with a haematological malignancy and healthy controls

van Sandwijk, M. S., Arashi, D. A., van de Hare, F. M., Rolien van der Torren, J. M., Kersten, M-J., Bijlsma, J. A., ten Berge, I. J. M. & Bemelman, F. J., 1 Jan 2019, In : Nephrology Dialysis Transplantation. 34, 5, p. 833-838

Research output: Contribution to journalArticleAcademicpeer-review

Long-term effectiveness and cost-effectiveness of an 18-week supervised exercise program in patients treated with autologous stem cell transplantation: results from the EXIST study

van Dongen, J. M., Persoon, S., Jongeneel, G., Bosmans, J. E., Kersten, M. J., Brug, J., Nollet, F., Chinapaw, M. J. M. & Buffart, L. M., 15 Aug 2019, In : Journal of Cancer Survivorship. 13, 4, p. 558-569 12 p.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

Phase II study of carfilzomib, thalidomide, and low-dose dexamethasone as induction and consolidation in newly diagnosed, transplant eligible patients with multiple myeloma; the Carthadex trial

Wester, R., Van Der Holt, B., Asselbergs, E., Zweegman, S., Kersten, M. J., Vellenga, E., Van Marwijk Kooy, M., De Weerdt, O., Minnema, M., Lonergan, S., Palumbo, A., Lokhorst, H., Broijl, A. & Sonneveld, P., 1 Jan 2019, In : Haematologica. 104, 11, p. 2265-2273 9 p.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

Physical activity in patients with cancer: self-report versus accelerometer assessments

Douma, J. A. J., de Beaufort, M. B., Kampshoff, C. S., Persoon, S., Vermaire, J. A., Chinapaw, M. J., van Mechelen, W., Nollet, F., Kersten, M. J., Smit, J. H., Verdonck-de Leeuw, I. M., Altenburg, T. M. & Buffart, L. M., 1 Jan 2019, In : Supportive Care in Cancer.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access
Open Access

Prognostic Significance of MYC Rearrangement and Translocation Partner in Diffuse Large B-Cell Lymphoma: A Study by the Lunenburg Lymphoma Biomarker Consortium

Rosenwald, A., Bens, S., Advani, R., Barrans, S., Copie-Bergman, C., Elsensohn, M-H., Natkunam, Y., Calaminici, M., Sander, B., Baia, M., Smith, A., Painter, D., Pham, L., Zhao, S., Ziepert, M., Jordanova, E. S., Molina, T. J., Kersten, M. J., Kimby, E., Klapper, W. & 16 others, Raemaekers, J., Schmitz, N., Jardin, F., Stevens, W. B. C., Hoster, E., Hagenbeek, A., Gribben, J. G., Siebert, R., Gascoyne, R. D., Scott, D. W., Gaulard, P., Salles, G., Burton, C., de Jong, D., Sehn, L. H. & Maucort-Boulch, D., 2019, In : Journal of Clinical Oncology. 37, 35, p. 3359-3368

Research output: Contribution to journalArticleAcademicpeer-review

Return to work experiences of patients treated with stem cell transplantation for a hematologic malignancy

Persoon, S., Buffart, L. M., Chinapaw, M. J. M., Nollet, F., Frings-Dresen, M. H., Koning, S., Kersten, M. J. & Tamminga, S. J., 1 Aug 2019, In : Supportive Care in Cancer. 27, 8, p. 2987-2997

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

Rituximab-PECC induction followed by 90Y-ibritumomab tiuxetan consolidation in relapsed or refractory DLBCL patients who are ineligible for or have failed ASCT: results from a phase II HOVON study

Lugtenburg, P. J., Zijlstra, J. M., Doorduijn, J. K., Böhmer, L. H., Hoogendoorn, M., Berenschot, H. W., Beeker, A., van der Burg-de Graauw, N. C., Schouten, H. C., Bilgin, Y. M., Kersten, M-J., Koene, H. R., Herbers, A. H. E., de Jong, D., Hijmering, N., Lam, K. H., Chiţu, D., Brouwer, R. E., van Imhoff, G. W. & the Dutch HOVON group, 1 Nov 2019, In : British Journal of Haematology. 187, 3, p. 347-355 9 p.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

Tailoring the amount of treatment information to cancer patients’ and survivors’ preferences: Effects on patient-reported outcomes

Lehmann, V., Labrie, N. H. M., van Weert, J. C. M., van Dulmen, S., de Haes, H. J. C. J. M., Kersten, M. J., Pieterse, A. H. & Smets, E. M. A., 26 Sep 2019, In : Patient Education and Counseling.

Research output: Contribution to journalArticleAcademicpeer-review

The NEDD8-activating enzyme inhibitor MLN4924 induces DNA damage in Ph+ leukemia and sensitizes for ABL kinase inhibitors

Bahjat, M., de Wilde, G., van Dam, T., Maas, C., Bloedjes, T., Bende, R. J., van Noesel, C. J. M., Luijks, D. M., Eldering, E., Kersten, M. J. & Guikema, J. E. J., 1 Jan 2019, In : Cell Cycle. 18, 18, p. 2307-2322

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

Treatment of patients with MYC rearrangement positive large B-cell lymphoma with R-CHOP plus lenalidomide: results of a multicenter HOVON phase II trial

Chamuleau, M. E. D., Burggraaff, C. N., Nijland, M., Bakunina, K., Mous, R., Lugtenburg, P. J., Dierickx, D., van Imhoff, G. W., Vermaat, J. S. P., Marijt, E. A. F., Visser, O., Mandigers, C., Bilgin, Y. M., Beeker, A., Durian, M. F., van Rees, B., Bohmer, L. H., Tick, L. W., Boersma, R. S., Snijders, T. J. F. & 12 others, Schouten, H. C., Koene, H. R., de Jongh, E., Hijmering, N., Diepstra, A., van den Berg, A., Arens, A. I. J., Huijbregts, J., Hoekstra, O., Zijlstra, J. M., de Jong, D. & Kersten, M. J., 19 Dec 2019, In : Haematologica.

Research output: Contribution to journalArticleAcademicpeer-review

2018

Interobserver variation in CD30 immunohistochemistry interpretation; consequences for patient selection for targeted treatment

Koens, L., van de Ven, P. M., Hijmering, N. J., Kersten, M. J., Diepstra, A., Chamuleau, M. & de Jong, D., 1 Sep 2018, In : Histopathology. 73, 3, p. 473-482 10 p.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

Thalidomide before and after autologous stem cell transplantation in recently diagnosed multiple myeloma (HOVON-50): long-term results from the phase 3, randomised controlled trial

van de Donk, N. W. CJ., van der Holt, B., Minnema, M. C., Vellenga, E., Croockewit, S., Kersten, M. J., von dem Borne, P. A., Ypma, P., Schaafsma, R., de Weerdt, O., Klein, S. K., Delforge, M., Levin, M-D., Bos, G. M., Jie, K-S. G., Sinnige, H., Coenen, J. L. LM., de Waal, E. G., Zweegman, S., Sonneveld, P. & 1 others, Lokhorst, H. M., 2018, In : The Lancet Haematology. 5, 10, p. e479-e492

Research output: Contribution to journalArticleAcademicpeer-review

2017

Carfilzomib Combined with Thalidomide and Low-Dose Dexamethasone for Remission Induction and Consolidation in Newly Diagnosed, Transplant Eligible Patients with Multiple Myeloma: The Carthadex Trial

Wester, R., van der Holt, B., Asselbergs, E., Zweegman, S., Kersten, M. J., Vellenga, E., van Marwijk Kooij, M., de Weerdt, O., Minnema, M. C., Lonergan, S., Palumbo, A., Lokhorst, H. M., Broyl, A., Iskander, K. S. & Sonneveld, P., 2017, In : Blood. 130, Suppl 1, p. 3141 LP - 3141

Research output: Contribution to journalArticleAcademicpeer-review

2016

Phase 2 Study of Carfilzomib, Thalidomide, and Low-Dose Dexamethasone As Induction/Consolidation in Newly Diagnosed, Transplant Eligible Patients with Multiple Myeloma, the Carthadex Trial

Wester, R., van der Holt, B., Asselbergs, E., van Duin, M., Zweegman, S., Kersten, M. J., Vellenga, E., Kooy, M. V. M., de Weerdt, O., Minnema, M., Lonergan, S., Palumbo, A., Lokhorst, H. M., Broijl, A. & Sonneveld, P., 2016, In : Blood. 128, 22, p. 1141 1 p.

Research output: Contribution to journalArticleAcademicpeer-review

The BETER survivorship care initiative for Hodgkin lymphoma; Tailored survivorship care for late effects of treatment

Dekker, N., Van'T Veer, M. B., Aleman, B. M. P., Van Leeuwen, F. E., Raemaekers, J. M. M., Schaapveld, M., Opstal-Van Winden, A., De Boer, J. P., Sombroek, C., Poortmans, P., Van Der Maazen, R., Lugtenburg, P. J. E., Janus, C., Noordijk, E., Krol, A. D. G. S., Daniels, L., Zijlstra, J., Meijer, O., Petersen, E., Buter, D. & 30 others, De Weijer, R., Roesink, J., Kluin-Nelemans, J. C. H., Van Imhoff, G., De Vries, F., Beijert, M., Kersten, M. J., Oldenburger, F., Dieleman, E., Schouten, H., Borger, J., Van De Voorde, L., Verschueren, K., Schippers, M., Verbeeten, B., Ong, F., Dorresteijn, L., Schimmel, E., Bouma, P., Muller, K., Lybeert, M., Dompeling, E., Manenschijn, A., Vos-Westerman, J. H., Van Kampen, D., Dielwart, M., Posthuma, W., Böhmer, L., Te Boome, L. & Visser, H., 1 Jan 2016, In : Nederlands Tijdschrift voor Geneeskunde. 160, 5

Research output: Contribution to journalArticleAcademicpeer-review

2015

Computed Tomography Observer Agreement in Staging Malignant Lymphoma

de Jong, A., Kwee, T. C., Quarles van Ufford, H. M. E., Beek, F. J. A., Quekel, L. G. B. A., de Klerk, J. M. H., Zijlstra, J. M., Fijnheer, R., Ludwig, I., Kersten, M. J., Stoker, J. & Nievelstein, R. A. J., 26 Nov 2015, In : Journal of Computer Assisted Tomography. 40, 2, p. 261-265 5 p.

Research output: Contribution to journalArticleAcademicpeer-review

2014

Relationship between pretreatment FDG-PET and diffusion-weighted MRI biomarkers in diffuse large B-cell lymphoma

de Jong, A., Kwee, T. C., de Klerk, J. M. H., Adam, J. A., de Keizer, B., Fijnheer, R., Kersten, M. J., Ludwig, I., Jauw, Y. W. S., Zijlstra, J. M., Pieters-Van den Bos, I. C., Stoker, J., Hoekstra, O. S. & Nievelstein, R. A. J., 2014, In : American journal of nuclear medicine and molecular imaging. 4, 3, p. 231-8 8 p.

Research output: Contribution to journalArticleAcademicpeer-review

2013

Bortezomib Induction and Maintenance Treatment Improves Survival In Patients With Newly Diagnosed Multiple Myeloma:Extended Follow-Up Of The HOVON-65/GMMG-HD4 Trial

Scheid, C., Holt, B. V. D., Jarari, L. E., Bertsch, U., Salwender, H., Zweegman, S., Vellenga, E., Broyl, A., Blau, I. W., Weisel, K., Wittebol, S., Bos, G. M. J., Stevens, M., Schmidt-Wolf, I. GH., Pfreundschuh, M., Hose, D., Jauch, A., Velde, H. V. D., Raymakers, R., Schaafsma, M. R. & 7 others, Kersten, M. J., Kooy, M. V. M., Duehrsen, U., Lindemann, H. W., Wijermans, P. W., Lokhorst, H. & Goldschmidt, H., 2013, In : Blood. 122, 21, p. 404-404 1 p.

Research output: Contribution to journalArticleAcademicpeer-review

2012

A285 The Dutch Lenalidomide Named Patient Program: Results and Feasibility in Heavily Pretreated Patients

Lokhorst, H., Wijermans, P., Kneppers, E., Huls, G., Wittebol, S., Sonneveld, P., Vellenga, E., Kersten, MJ., Zweegman, S., Schaafsma, M., Raymakers, RA. & Eeltink, C., 27 Sep 2012, In : Clinical Lymphoma and Myeloma. 9, p. S47-S48

Research output: Contribution to journalArticleAcademicpeer-review

A288 Non-Myeloablative Allo-SCT for Relapsed Myeloma: A Single-Center Experience

Lokhorst, H., van Dorp, S., Schouten, F., Schaafsma, R., Schouten, H., Coenen, J., Kersten, MJ., Minnema, MC., Zweegman, S. & van de Donk, N., 27 Sep 2012, In : Clinical Lymphoma and Myeloma. 9, p. S48

Research output: Contribution to journalArticleAcademicpeer-review

B152 First Analysis of HOVON-65/GMMG-HD4 Randomized Phase III Trial Comparing Bortezomib, Doxorubicin, Dexamethasone (PAD) vs. VAD as Induction Treatment Prior to High-dose Melphalan (HDM) in Patients with Newly Diagnosed Multiple Myeloma (MM)

Lokhorst, HM., Sonneveld, P., Hose, D., Schmidt-Wolf, IGH., Eljarari, L., Vellenga, E., Jauch, A., Wijermans, PW., Schubert, J., Bertsch, U., Kersten, MJ., De Weerdt, O., Van Der Holt, B., Blau, IW., Delforge, M., Van Der Griend, R., Van Der Velde, H., Jie, GSK., Beverloo, B., Salwender, H. & 4 others, Zweegman, S., Schaafsma, R., Goldschmidt, H. & Martin, H., 27 Sep 2012, In : Clinical Lymphoma and Myeloma. 9, p. S105-S106

Research output: Contribution to journalArticleAcademicpeer-review

Carfilzomib Combined with Thalidomide and Dexamethasone (CTD) Is an Highly Effective Induction and Consolidation Treatment in Newly Diagnosed Patients with Multiple Myeloma (MM) who are transplant candidate

Sonneveld, P., Asselbergs, E., Zweegman, S., Holt, B. V. D., Kersten, M. J., Vellenga, E., Marwijk-Kooy, M. V., Weerdt, O. D., Lonergan, S. & Lokhorst, H., 2012, In : Blood. 120, p. Abstract #333

Research output: Contribution to journalArticleAcademicpeer-review

2011

Laboratoriumonderzoek bij monoklonale gammopathie: detectie van monoklonale immuunglobulinen

Ruinemans-Koerts, J; Boonstra, J. G., Klasen, I. S., Zweegman, S., Minnema, M. C., Wegman, J. J., Kersten, M. J. & Dinkelaar, R. B., 2011, In : Nederlands Tijdschrift voor Hematologie. 4, p. 160-168 9 p.

Research output: Contribution to journalArticleAcademicpeer-review

2000

Phase I trial of combined immunotherapy with subcutaneous granulocyte macrophage colony-stimulating factor, low-dose interleukin 2, and interferon α in progressive metastatic melanoma and renal cell carcinoma

de Gast, G. C., Klümpen, H-J., Vyth-Dreese, F. A., Kersten, M-J., Verra, N. C. V., Sein, J., Batchelor, D., Nooijen, W. J. & Schornagel, J. H., 2000, In : Clinical Cancer Research. 6, 4, p. 1267-1272

Research output: Contribution to journalArticleAcademicpeer-review